| 1 | [SID74373654] | Active | AC50 | 5.216 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells [AID449748, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | AC50 | 5.216 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells | | AID | 449748 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID74373654] | Active | AC50 | 6.56 | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP [AID463074, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | AC50 | 6.56 [uM] | | BioAssay | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP | | AID | 463074 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID74373654] | Active | AbsAC1000_uM | 8.116 | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity [AID540271, Type: confirmatory] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | AbsAC1000_uM | 8.116 [uM] | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity | | AID | 540271 | | BioAssay type | confirmatory | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 4 | [SID74373654] | Active | AbsAC35_uM | 8.77 | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity [AID652041, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | AbsAC35_uM | 8.77 [uM] | | BioAssay | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity | | AID | 652041 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID74373654] | Active | IC50 | 13.6 | Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay [AID624167, Type: confirmatory] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | IC50 | 13.6 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay | | AID | 624167 | | BioAssay type | confirmatory | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 6 | [SID74373654] | Active | AbsAC35_uM | 15.32 | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity [AID652047, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | AbsAC35_uM | 15.32 [uM] | | BioAssay | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity | | AID | 652047 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID74373654] | Active | Potency | 18.3564 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 8 | [SID74373654] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID74373654] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID74373654] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID74373654] | Active | AbsAC35_uM | 39.18 | Mammalian cell toxicity counterscreen to identify toxic HSP40 inhibitor compounds in NIH3T3 cells Measured in Cell-Based System Using Plate Reader - 2120-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID624265, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | AbsAC35_uM | 39.18 [uM] | | BioAssay | Mammalian cell toxicity counterscreen to identify toxic HSP40 inhibitor compounds in NIH3T3 cells Measured in Cell-Based System Using Plate Reader - 2120-03_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 624265 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID74373654] | Active | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts [AID652141, Type: screening] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts | | AID | 652141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID74373654] | Active | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. [AID2023, Type: screening] | LAP4 [Saccharomyces cerevisiae] [gi:486173] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. | | AID | 2023 | | BioAssay type | screening | | Target | LAP4 [Saccharomyces cerevisiae] [gi:486173] | | PubMed | | | Data Table |  |
|
| 14 | [SID74373654] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID74373654] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 16 | [SID74373654] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 17 | [SID74373654] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 18 | [SID74373654] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 19 | [SID74373654] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 20 | [SID74373654] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 21 | [SID74373654] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 22 | [SID74373654] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 23 | [SID74373654] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 24 | [SID74373654] | Active | | | Counterscreen for antagonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective antagonists [AID651780, Type: screening] | GNA15 gene product [Homo sapiens] [gi:156104883] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Counterscreen for antagonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective antagonists | | AID | 651780 | | BioAssay type | screening | | Target | GNA15 gene product [Homo sapiens] [gi:156104883] | | PubMed | | | Data Table |  |
|
| 25 | [SID74373654] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 26 | [SID74373654] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 27 | [SID74373654] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 28 | [SID74373654] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 29 | [SID74373654] | Active | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 30 | [SID74373654] | Active | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 31 | [SID74373654] | Active | | | Single concentration confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504550, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Single concentration confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504550 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 32 | [SID74373654] | Active | | | Single concentration confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504550, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Single concentration confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504550 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 33 | [SID74373654] | Active | IC50 | | Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay [AID624167_4, Type: confirmatory] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay | | AID | 624167 | | BioAssay type | confirmatory | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 34 | [SID74373654] | Active | | | Single concentration confirmation of uHTS hits for Peg3 Promoter Inhibitors via a luciferase reporter assay [AID602417, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for Peg3 Promoter Inhibitors via a luciferase reporter assay | | AID | 602417 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 35 | [SID74373654] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 36 | [SID74373654] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 37 | [SID74373654] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 38 | [SID74373654] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID651785, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 651785 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 39 | [SID74373654] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID651785, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 651785 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 40 | [SID74373654] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 41 | [SID74373654] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 42 | [SID74373654] | Active | | | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity [AID504582, Type: screening] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504582 | | BioAssay type | screening | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 43 | [SID74373654] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID588726, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 588726 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 44 | [SID74373654] | Active | | | Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID651616, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 651616 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 45 | [SID74373654] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 46 | [SID74373654] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 47 | [SID74373654] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay [AID624167_5, Type: confirmatory] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay | | AID | 624167 | | BioAssay type | confirmatory | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 48 | [SID74373654] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay [AID624167_6, Type: confirmatory] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay | | AID | 624167 | | BioAssay type | confirmatory | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 49 | [SID74373654] | Inactive | Potency | 25.1189 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 50 | [SID74373654] | Inactive | Potency | 25.1189 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 74373654 | | CID | 56603528 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|